Cigna Corp (CI)
$353.99
7.52 (2.17%)
CI Stock Quote Delayed 30 Minutes
The Perfect Prescription for Profits
There’s a lot to be said for going with the category killer in an investment. A merger is creating exactly that in the prescription service space.
Top 5 Stocks for 2024
INSIDE: Investing legend Louis Navellier reveals his Top 5 Stocks for 2024 — FREE!
Download His Free Report Here:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
120.39B
PE Ratio
27.83
EPS
12.72
Volume (Avg. Vol.)
1.43M
Day's Range
$346.15 - $354.49
52-Week Range
$253.95 - $365.71
Dividend & Yield
$4.92 (1.39%)
CI Stock Predictions, Articles, and Cigna Corp News
Pharma Firms Duke It Out — Monday’s IP Market Recap
Pharmasset (VRUS) and Inhibitex (INHX) jump on positive hepatitis C drug news, and Vertex (VRTX) stock gets knocked back.
Boeing, 787 Dreamliner Flying High — Wednesday’s IP Market Recap
Boeing (BA) has a doubly good day, posting successful Q3 earnings and celebrating a successful 787 Dreamliner launch. Meanwhile, Amazon (AMZN) got hit as expected.
Stock Your Portfolio With Walgreen, Not CVS
Both CVS and Walgreen are fairly valued, but one stock is a more attractive investment. The winner is ...
5 Great Long-Term Growth Stocks
These "Long Hauler" stocks might not always be exciting, but they'll truck along to the tune of solid gains.
Campaign to Kill Medco-Express Scripts Deal Likely Futile
It's not very likely that major pharmaceuticals will be able to prevent Express Scripts from acquiring Medco. But they do have good reason to try.
Sides Form on Medco-Express Scripts Deal
With the Federal Trade Commission likely to give the deal a close eye, analysts and investors sound off varying degrees of optimism and pessimism about this venture.
3 Big-Name Stocks That May Be Bankrupt Soon
Borders is quickly being put out to pasture -- now, it's time to keep an eye on three more companies that could be on their last legs.
SFN, Medco Continue to Top Trading
Midday Trading Led By SFN Group (NYSE: SFN), Medco Health Solutions (NYSE: MHS), Express Scripts (NASDAQ: ESRX).
S&P 500 Thrives on Strong Earnings, Mergers
Robert Half International (RHI) upgrade, Medco (MHS) merger with Express Scripts (ERSX) among biggest news across uplifted S&P 500.
Medco, Express Scripts Skyrocket on Deal
Midday Stock Volume Led By Medco Health Solutions (NYSE: MHS), SFN Group (NYSE: SFN), Express Scripts (NASDAQ: ESRX).
Walgreens vs. CVS Caremark: Which Stock Will Win Drug Store Wars?
One of these stocks has the advantage in the drug store wars. Which one?
